Delayed activin A administration attenuates tissue death after transient focal cerebral ischemia and is associated with decreased stress-responsive kinase activation
Document Type
Journal Article
Publication Date
12-1-2009
Journal
Journal of Neurochemistry
Volume
111
Issue
5
DOI
10.1111/j.1471-4159.2009.06406.x
Keywords
Activin A; Ischemic reperfusion injury; Neuroprotection; Stress activated kinases
Abstract
Focal cerebral ischemia and reperfusion initiates complex cellular and molecular interactions that lead to either cell repair or destruction. In earlier work, we found that activin A is an early gene response to cerebral ischemia and supports cortical neuron survival in vitro. In this study, the ability of exogenous activin A to attenuate injury from transient middle cerebral artery occlusion was tested in adult mice. Intracerebroventricular administration of activin A prior to middle cerebral artery occlusion reduced infarct volume apparent 1 day after experimental stroke. A single activin A administration at 6 h following ischemia/reperfusion reduced lesion volumes at 1 and 3 days and led to improved neurobehavior. Moreover, activin A treatment spared neurons within the ischemic hemisphere and led to a concomitant reduction in microglial activation. Activation of the stress-responsive kinases p38 and c-jun N-terminal kinase implicated in neuronal apoptosis after stroke was reduced following activin A treatment. Together these findings suggest that activin A promotes tissue survival after focal cerebral ischemia/reperfusion with an extended therapeutic window. © 2009 International Society for Neurochemistry.
APA Citation
Mukerji, S., Rainey, R., Rhodes, J., & Hall, A. (2009). Delayed activin A administration attenuates tissue death after transient focal cerebral ischemia and is associated with decreased stress-responsive kinase activation. Journal of Neurochemistry, 111 (5). http://dx.doi.org/10.1111/j.1471-4159.2009.06406.x